Medication Nonadherence in Diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the longitudinal effects of medication nonadherence (MNA) on key costs and estimate potential savings from increased adherence using a novel methodology that accounts for shared correlation among cost categories. RESEARCH DESIGN AND METHODS: Veterans with type 2 diabetes (740,195) were followed from January 2002 until death, loss to follow-up, or December 2006. A novel multivariate, generalized, linear, mixed modeling approach was used to assess the differential effect of MNA, defined as medication possession ratio (MPR) ≥0.8 on healthcare costs. A sensitivity analysis was performed to assess potential cost savings at different MNA levels using the Consumer Price Index to adjust estimates to 2012 dollar value. RESULTS: Mean MPR for the full sample over 5 years was 0.78, with a mean of 0.93 for the adherent group and 0.58 for the MNA group. In fully adjusted models, all annual cost categories increased ∼3% per year (P = 0.001) during the 5-year study time period. MNA was associated with a 37% lower pharmacy cost, 7% lower outpatient cost, and 41% higher inpatient cost. Based on sensitivity analyses, improving adherence in the MNA group would result in annual estimated cost savings ranging from ∼$661 million (MPR <0.6 vs. ≥0.6) to ∼$1.16 billion (MPR <1 vs. 1). Maximal incremental annual savings would occur by raising MPR from <0.8 to ≥0.8 ($204,530,778) among MNA subjects. CONCLUSIONS: Aggressive strategies and policies are needed to achieve optimal medication adherence in diabetes. Such approaches may further the so-called “triple aim” of achieving better health, better quality care, and lower cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
The Triple Aim: Care, Health, And Cost
Berwick, D. M., Nolan, T. W., & Whittington, J. (2008) · Health Affairs · doi:10.1377/hlthaff.27.3.759 · Cited by 5,136
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176 · cited 2×
“In general, these investigators concluded that most successful methods for improving chronic medication adherence were complex, labor intensive, and not predictably effective (19).”
BackgroundReview of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767 · cited 2×
“In addition, most analyses fail to appropriately account for the shared correlation among cost variables (11).”
BackgroundDoes Free Care Improve Adults' Health?: Results from a Randomized Controlled Trial
Brook, R. H., Ware, J. E., Rogers, W. H., Keeler, E. B., Davies, A. R., Donald, C. A., Goldberg, G. A., Lohr, K. N., Masthay, P. C., & Newhouse, J. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092305 · Cited by 666 · cited 1×
“This is consistent with an earlier experience in the Rand health insurance experiment (25); although we should note that our study was not designed to specifically examine the effects of copayments on medication adherence.”
ResultHanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Impact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602 · cited 2×
“$100 billion spent each year on avoidable hospitalizations (1,2).”
BackgroundMiller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425 · cited 1×
“hypoglycemic agents in 2002 based on a previously validated algorithm (12).”
MethodThe association between diabetes metabolic control and drug adherence in an indigent population
Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1015 · Cited by 373
Balkrishnan, R., Rajagopalan, R., Camacho, F. T., Huston, S. A., Murray, F. T., & Anderson, R. T. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80347-8 · Cited by 350 · cited 2×
“(10) previously found that each 10% increase in adherence was associated with an 8.”
BackgroundLau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 318 · cited 2×
“For example, Lau and Nau (9) found that patients with type 2 diabetes who did not obtain at least 80% of their oral hypoglycemic medications across 1 year were at higher risk of hospitalization in the following year.”
BackgroundKerr, E. A., Gerzoff, R. B., Krein, S. L., Selby, J. V., Piette, J. D., Curb, J. D., Herman, W. H., Marrero, D. G., Narayan, K. M. V., Safford, M. M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-4-200408170-00007 · Cited by 290
Engagement in a Diabetes Self-management Website: Usage Patterns and Generalizability of Program Use
Glasgow, R. E., Christiansen, S. M., Kurz, D., King, D. K., Woolley, T., Faber, A. J., Estabrooks, P. A., Strycker, L., Toobert, D., & Dickman, J. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1391 · Cited by 219
Barnett, M., Frank, J., Wehring, H., Newland, B., VonMuenster, S., Kumbera, P., Halterman, T., & Perry, P. J. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.1.18 · Cited by 185 · cited 1×
“Currently, reimbursement for medication review is either very low or nonexistent by third party payers and thus should be a focus of policy change (30).”
BackgroundDefining “Rural” for Veterans’ Health Care Planning
West, A. N., Lee, R. E., Shambaugh-Miller, M. D., Bair, B. D., Mueller, K. J., Lilly, R. S., Kaboli, P. J., & Hawthorne, K. (2010) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2010.00298.x · Cited by 143 · cited 1×
“Location of residence was defined as urban and rural/ highly rural (14), and hospital region was defined by the five geographic regions of the country based on VHA Veterans Integrated Service Networks (VISNs): Northeast (VISNs 1, 2, and 3), Mid-Atlantic (VISNs 4, 5, 6, 9, and 10), South (VISNs 7, 8, 16, and 17), Midwe…”
BackgroundSalas, M., Hughes, D. A., Zuluaga, A., Vardeva, K., & Lebmeier, M. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00539.x · Cited by 141 · cited 1×
“8 are considered to imply good adherence (6,8).”
BackgroundWilliams, M. E., Pulliam, C. C., Hunter, R., Johnson, T. M., Owens, J. E., Kincaid, J., Porter, C., & Koch, G. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52016.x · Cited by 136
The Influence of Insulin Use on Glycemic Control
Cramer, J. A., & Pugh, M. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.78 · Cited by 134
Random-effects models for multivariate repeated measures
Fieuws, S., Verbeke, G., & Molenberghs, G. (2007) · Statistical Methods in Medical Research · doi:10.1177/0962280206075305 · Cited by 102 · cited 1×
“To model the relationship between the three cost categories and covariates, a joint model based on an mGLMM approach with shared random intercept was used (see Supplementary Appendix) (17).”
MethodIncreasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
Maciejewski, M. L., Bryson, C. L., Perkins, M. W., Blough, D. K., Cunningham, F. E., Fortney, J. C., Krein, S. L., Stroupe, K. T., Sharp, N. D., & Liu, C. (2010) · PubMed · Cited by 79
McWilliams, J. M., Zaslavsky, A. M., & Huskamp, H. A. (2011) · JAMA · doi:10.1001/jama.2011.1026 · Cited by 69 · cited 1×
“reductions in nondrug medical spending for Medicare beneficiaries with limited prior drug coverage (26).”
BackgroundThe Cost‐Effectiveness of a Clinical Pharmacist Intervention Among Elderly Outpatients
Cowper, P. A., Weinberger, M., Hanlon, J. T., Landsman, P. B., Samsa, G. P., Uttech, K. M., Schmader, K. E., Lewis, I. K., Cohen, H. J., & Feussner, J. R. (1998) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03858.x · Cited by 67
Shenolikar, R. A., Balkrishnan, R., Camacho, F., Whitmire, J. T., & Anderson, R. T. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.012 · Cited by 58 · cited 1×
“(18) reported that a 10% increase in adherence was associated with a 2% reduction in total medical costs and 4% reduction in diabetes-related medical costs.”
BackgroundTrivedi, A. N., & Grebla, R. C. (2011) · Medical Care · doi:10.1097/mlr.0b013e31820fb0f6 · Cited by 57 · cited 1×
“Second, although our research group and others have previously demonstrated that racial/ethnic, geographic, and rural/urban disparities exist in diabetes medication adherence and health outcomes (32,33), there is evidence that quality and equity of care for diabetes is higher within the VHA system (34,35).”
BackgroundGhorob, A., Vivas, M. M., De Vore, D., Ngo, V., Bodenheimer, T., Chen, E., & Thom, D. H. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-208 · Cited by 56
Longitudinal Differences in Glycemic Control by Race/Ethnicity Among Veterans With Type 2 Diabetes
Egede, L. E., Mueller, M., Echols, C. L., & Gebregziabher, M. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d558dc · Cited by 41 · cited 1×
“Second, although our research group and others have previously demonstrated that racial/ethnic, geographic, and rural/urban disparities exist in diabetes medication adherence and health outcomes (32,33), there is evidence that quality and equity of care for diabetes is higher within the VHA system (34,35).”
BackgroundSelf-citationEgede, L. E., Strom, J. L., Fernandes, J., Knapp, R. G., & Rojugbokan, A. (2011) · Trials · doi:10.1186/1745-6215-12-231 · Cited by 24
Self-citationthe ADDITION-Plus study team, Griffin, S. J., Simmons, R. K., Williams, K. M., Prevost, A. T., Hardeman, W., Grant, J., Whittle, F., Boase, S., Hobbis, I., et al. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-211 · Cited by 23
Disparities in diabetes self-management and quality of care in rural versus urban veterans
Lynch, C. P., Strom, J. L., & Egede, L. E. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.08.003 · Cited by 17 · cited 1×
“Second, although our research group and others have previously demonstrated that racial/ethnic, geographic, and rural/urban disparities exist in diabetes medication adherence and health outcomes (32,33), there is evidence that quality and equity of care for diabetes is higher within the VHA system (34,35).”
BackgroundSelf-citationImproving Medication Adherence Promises Great Payback, but Poses Tough Challenge
Mitka, M. (2010) · JAMA · doi:10.1001/jama.2010.212 · Cited by 12 · cited 1×
“Although MNA has historically received little attention, it has been recognized that improving adherence rates could dramatically impact patient outcomes while reducing overall health care spending (36).”
BackgroundThe Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion
Balfour, D. C., III, Evans, S., Januska, J., Lee, H. Y., Lewis, S. J., Nolan, S. R., Noga, M., Stemple, C., & Thapar, K. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s1.18 · Cited by 11
Cited by
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Adherence and health care costs
McGuire, M., & Iuga (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 708
Importance of family/social support and impact on adherence to diabetic therapy
Miller, T., & DiMatteo, R. (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s36368 · Cited by 437
Medication Adherence With Diabetes Medication: A Systematic Review of the Literature
Capoccia, K., Odegard, P. S., & Letassy, N. (2016) · The Diabetes Educator · doi:10.1177/0145721715619038 · Cited by 291
Metadata
- Authors
- Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Egede, Leonard E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2533-2539
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3507586
- OpenAlex
- W2147325147
- Cited by
- 195
- References
- 33
- Citations by year
- 2026: 2 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 9 · 2021: 17 · 2020: 23 · 2019: 15 · 2018: 20 · 2017: 12 · 2016: 17 · 2015: 16 · 2014: 20 · 2013: 9 · 2012: 1
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Health Services Research and Development
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- medication non-adherence, type 2 diabetes, health care costs, medication possession ratio, cost reduction, veterans, hospital costs, outpatient costs, pharmacy costs, generalized linear mixed models, Triple Aim
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Models, Statistical, Drug Monitoring, Cost Savings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.